Skip to main content

Geeta Krishna Swamy, MD

Property title
Professor of Obstetrics and Gynecology
Campus Mail: Box 3967 Med Ctr, Durham, NC 27710
Phone: (919) 681-5220
Email: swamy002@mc.duke.edu

Dr. Geeta Swamy, MD, became Vice Chair for Research and Faculty Development in the Department of Obstetrics and Gynecology on March 1, 2018. In this dual role, Dr. Swamy oversees strategic development and administration of the Department’s basic, translational and clinical research programs, as well as implements and oversees programs to support development and mentorship for all faculty at all levels.

Dr. Swamy has also been instrumental in developing and leading the School of Medicine’s Research Regulatory and Compliance initiatives, first as Chair of the IRB and then as Senior Associate Dean for Clinical Research for Regulatory Oversight and Research Initiatives. In 2018, she became Vice Dean for Scientific Integrity and Associate Vice President for Research for Duke University. In these roles she oversees the Duke Office of Scientific Integrity (DOSI) which houses the Advancing Scientific Integrity, Services, & Training (ASIST) initiative, conflict of interest, clinical quality management, incident response in research, and research misconduct. She also oversees the Duke Office of Research Initiatives which includes the research onboarding and navigation programs.

Dr. Swamy has dedicated her career to advancing research in women’s health and to mentoring faculty and trainees. She is an internationally recognized clinician-researcher, and an expert and nationally-recognized leader in the field of maternal immunization and vaccination in pregnancy. Her research has been funded by the National Institutes of Health (NIH), Centers for Disease Control (CDC), Environmental Protection Agency (EPA) and others. She currently serves as the Co-Principal Investigator for the NIH-NIAID Vaccine Treatment and Evaluation (VTEU) and CDC-funded Clinical Immunization Safety Assessment, and has published over 100 peer-reviewed manuscripts. Dr. Swamy has been the Director of the Duke Perinatal Research Center since 2010. Dr. Swamy's focused area of interests are perinatal infection, maternal immunization and preterm birth.

Education and Training

  • Resident, Obstetrics And Gynecology, University of Pittsburgh, 1997 - 2001
  • M.D., University of North Carolina - Chapel Hill, 1997

Selected Grants and Awards

Publications

Andrikopoulou, Maria, Elisa T. Bushman, Madeline M. Rice, William A. Grobman, Uma M. Reddy, Robert M. Silver, Yasser Y. El-Sayed, et al. “Maternal and Neonatal Outcomes in Nulliparous Participants Undergoing Labor Induction by Cervical Ripening Method.” Am J Perinatol, August 5, 2021. https://doi.org/10.1055/s-0041-1732379.

Full Text

Battarbee, Ashley N., Grecio Sandoval, William A. Grobman, Uma M. Reddy, Alan T. N. Tita, Robert M. Silver, Yasser Y. El-Sayed, et al. “Maternal and Neonatal Outcomes Associated with Amniotomy among Nulliparous Women Undergoing Labor Induction at Term.” American Journal of Perinatology 38, no. S 01 (August 2021): e239–48. https://doi.org/10.1055/s-0040-1709464.

Full Text

Hughes, Brenna L., Rebecca G. Clifton, Dwight J. Rouse, George R. Saade, Mara J. Dinsmoor, Uma M. Reddy, Robert Pass, et al. “A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.” N Engl J Med 385, no. 5 (July 29, 2021): 436–44. https://doi.org/10.1056/NEJMoa1913569.

Full Text

Guptill, J. T., S. M. Raja, V. C. Juel, E. B. Walter, M. Cohen-Wolkowiez, H. Hill, E. Sendra, B. Hauser, P. Jackson, and G. K. Swamy. “Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.” Antimicrob Agents Chemother 65, no. 7 (June 17, 2021): e0232920. https://doi.org/10.1128/AAC.02329-20.

Full Text

Gyamfi-Bannerman, Cynthia, Kathleen A. Jablonski, Sean C. Blackwell, Alan T. N. Tita, Uma M. Reddy, Lucky Jain, George R. Saade, et al. “Evaluation of Hypoglycemia in Neonates of Women at Risk for Late Preterm Delivery: An Antenatal Late Preterm Steroids Trial Cohort Study.” American Journal of Perinatology, May 27, 2021. https://doi.org/10.1055/s-0041-1729561.

Full Text

Craig, Amanda M., Brenna L. Hughes, and Geeta K. Swamy. “Reply to: Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data.” Am J Obstet Gynecol Mfm 3, no. 3 (May 2021): 100323. https://doi.org/10.1016/j.ajogmf.2021.100323.

Full Text

Dotters-Katz, Sarah K., Hailey Harris, Sarahn M. Wheeler, Geeta K. Swamy, and Brenna L. Hughes. “Specialized prenatal care delivery for coronavirus disease 2019-exposed or -infected pregnant women.” Am J Obstet Gynecol 224, no. 3 (March 2021): 325–27. https://doi.org/10.1016/j.ajog.2020.11.025.

Full Text

Tita, Alan T. N., Lindsay Doherty, William A. Grobman, Uma M. Reddy, Robert M. Silver, Gail Mallett, Madeline Murguia Rice, et al. “Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.” Obstet Gynecol 137, no. 2 (February 1, 2021): 250–57. https://doi.org/10.1097/AOG.0000000000004230.

Full Text

Pages